FDA
approval
· 2024-07-29
FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for a citalopram hydrobromide product manufactured by Aurobindo Pharma Limited.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM (CITALOPRAM HYDROBROMIDE)